Sort by
Search results
Factor IX EIA
Supplied with full step-by-step instructions for performing sandwich ELISAs. For research use only.
Factor IX Deficient Plasma
Measurement of factor IX (FIX) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent). For any in vitro protocol or research study where a source of human FIX deficient plasma is required.
FVIII Inhibitor Plasma (1) mild (1-10 BU/ml), lyophilized
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
Kallikrein, Human, gereinigt
Kallikrein, human, purified (Plasma)
Kininogen Deficient Plasma, frozen
For any in vitro protocol or research study where a source of human kininogen deficient plasma is required.
Imidazole buffer pH 7.30
Buffer for clotting assays (plasma samples). Diluent for plasma
Imidazole buffer pH 7.30
Buffer for clotting assays (plasma samples). Diluent for plasma
BIOPHEN Heparin LRT 3 (Liquid Reagent Technology)
Measuring the concentration of UFH, LMWH, Arixtra ® , Orgaran ® , rivaroxaban (Xarelto ® ), apixaban (Eliquis ® ) and edoxaban (Lixiana ® ) in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN Heparin LRT 7.5 (Liquid Reagent Technology)
Measuring the concentration of UFH, LMWH, Arixtra ® , Orgaran ® , rivaroxaban (Xarelto ® ), apixaban (Eliquis ® ) and edoxaban (Lixiana ® ) in patients’ plasma for monitoring the therapy and adjusting drug dosage.
CEPHEN APTT LS 2.5 (Lupus Sensitive)
Measurement of the plasma recalcification time, in presence of the standardized aPTT (activated partial thromboplastin time) reagent (cephalin and activator), on human citrated plasma, to explore the activity of the intrinsic pathway coagulation factors (II, V, VIII, IX, X, XI, XII) and “anticoagulant” activities.